UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The international journal of neuropsychopharmacology, ISSN 1461-1457, 07/2016, Volume 19, Issue 7, p. pyw018
long-acting injectable | paliperidone palmitate 3-month | schizophrenia | relapse-free | paliperidone palmitate 1-month | Neurosciences | Clinical Neurology | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Neurosciences & Neurology | Psychiatry | Science & Technology | Paliperidone Palmitate - blood | Antipsychotic Agents - blood | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Male | Secondary Prevention | Dose-Response Relationship, Drug | Young Adult | Paliperidone Palmitate - adverse effects | Time Factors | Antipsychotic Agents - therapeutic use | Delayed-Action Preparations - pharmacokinetics | Adult | Female | Double-Blind Method | Schizophrenia - blood | Treatment Outcome | Antipsychotic Agents - pharmacokinetics | Injections, Intramuscular | Paliperidone Palmitate - therapeutic use | Delayed-Action Preparations - adverse effects | Paliperidone Palmitate - pharmacokinetics | Adolescent | Delayed-Action Preparations - therapeutic use | Aged | Schizophrenia - drug therapy | Index Medicus
Journal Article
Psychological medicine, ISSN 0033-2917, 09/2018, Volume 48, Issue 12, pp. 2098 - 2099
Journal Article
Nature (London), ISSN 0028-0836, 2014, Volume 511, Issue 7510, pp. 421 - 427
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Schizophrenia | Genetic research | Research | Health aspects | Analysis | Studies | Confidence intervals | Hypotheses | Genealogy | Sample size | Genomics | Genetics | Trends | Index Medicus | Medicin och hälsovetenskap
Journal Article
Schizophrenia research, ISSN 0920-9964, 2009, Volume 116, Issue 2, pp. 107 - 117
Psychiatry | Long-acting therapy | Schizophrenia | Relapse | Atypical antipsychotic | Paliperidone palmitate | Severity of Illness Index | Double-Blind Method | Follow-Up Studies | Pyrimidines - administration & dosage | Humans | Middle Aged | Paliperidone Palmitate | Male | Isoxazoles - administration & dosage | Antipsychotic Agents - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Psychiatric Status Rating Scales | Palmitates - administration & dosage | Adolescent | Adult | Female | Aged | Schizophrenia - drug therapy | Drug Delivery Systems - methods | Medicine, Experimental | Medical research | Care and treatment | Antipsychotic drugs | Index Medicus
Journal Article
The journal of clinical psychiatry, ISSN 0160-6689, 07/2017, Volume 78, Issue 7, pp. e813 - e820
Psychology, Clinical | Social Sciences | Life Sciences & Biomedicine | Psychiatry | Psychology | Science & Technology | Recurrence | Double-Blind Method | Risk Assessment | Schizophrenia - blood | Administration, Oral | Humans | Half-Life | Male | Structure-Activity Relationship | Injections, Intramuscular | Schizophrenic Psychology | Paliperidone Palmitate - administration & dosage | Paliperidone Palmitate - adverse effects | Paliperidone Palmitate - pharmacokinetics | Substance Withdrawal Syndrome - blood | Adult | Female | Schizophrenia - drug therapy | Delayed-Action Preparations | Index Medicus
Journal Article
Schizophrenia research, ISSN 0920-9964, 2012, Volume 138, Issue 1, pp. 29 - 34
Psychiatry | Refractory | Clinical trial | Injection | Paliperidone palmitate | Post hoc | Life Sciences & Biomedicine | Science & Technology | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Schizophrenia | Biological and medical sciences | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psycholeptics: tranquillizer, neuroleptic | Psychoses | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Palmitates - therapeutic use | Recurrence | Humans | Middle Aged | Paliperidone Palmitate | Male | Treatment Outcome | Clinical Trials as Topic | Antipsychotic Agents - therapeutic use | Placebos - adverse effects | Treatment Failure | Adult | Female | Isoxazoles - therapeutic use | Schizophrenia - drug therapy | Clinical trials | Analysis | Index Medicus
Journal Article
JAMA psychiatry (Chicago, Ill.), ISSN 2168-622X, 08/2015, Volume 72, Issue 8, pp. 830 - 839
Life Sciences & Biomedicine | Psychiatry | Science & Technology | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Male | Secondary Prevention - methods | Dose-Response Relationship, Drug | Young Adult | Palmitates - administration & dosage | Antipsychotic Agents - therapeutic use | Schizophrenia - prevention & control | Adult | Female | Palmitates - adverse effects | Palmitates - therapeutic use | Double-Blind Method | Paliperidone Palmitate | Treatment Outcome | Isoxazoles - administration & dosage | Antipsychotic Agents - administration & dosage | Delayed-Action Preparations - adverse effects | Adolescent | Delayed-Action Preparations - therapeutic use | Aged | Isoxazoles - therapeutic use | Schizophrenia - drug therapy | Isoxazoles - adverse effects | Schizophrenia | Clinical trials | Placebos | Care and treatment | Usage | Index Medicus | Abridged Index Medicus
Journal Article
The international journal of neuropsychopharmacology, ISSN 1461-1457, 02/2012, Volume 15, Issue 1, pp. 107 - 118
second-generation antipsychotics | Atypical antipsychotic | risperidone | intramuscular | long-acting injectables | schizophrenia | paliperidone palmitate | efficacy | Neurosciences | Clinical Neurology | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Neurosciences & Neurology | Psychiatry | Science & Technology | Antipsychotic Agents - adverse effects | Humans | Male | Delayed-Action Preparations - administration & dosage | Sleep Initiation and Maintenance Disorders - chemically induced | Psychiatric Status Rating Scales | Palmitates - administration & dosage | Schizophrenia - physiopathology | Risperidone - adverse effects | Adult | Female | Palmitates - adverse effects | Buttocks | Double-Blind Method | Administration, Oral | Risperidone - administration & dosage | Paliperidone Palmitate | European Continental Ancestry Group | Treatment Outcome | Injections, Intramuscular | Isoxazoles - administration & dosage | Antipsychotic Agents - administration & dosage | Delayed-Action Preparations - adverse effects | Schizophrenia - drug therapy | Isoxazoles - adverse effects | Index Medicus
Journal Article
Progress in neuro-psychopharmacology & biological psychiatry, ISSN 0278-5846, 01/2011, Volume 35, Issue 1, pp. 218 - 226
Schizophrenia | Gluteal injection | Atypical antipsychotic | Risperidone long-acting injectable | Paliperidone palmitate | Deltoid injection | Neurosciences | Clinical Neurology | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Neurosciences & Neurology | Psychiatry | Science & Technology | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Biological and medical sciences | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psycholeptics: tranquillizer, neuroleptic | Psychoses | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Isoxazoles - pharmacokinetics | Palmitates - therapeutic use | Double-Blind Method | Humans | Middle Aged | Paliperidone Palmitate | Risperidone - pharmacokinetics | Male | Treatment Outcome | Antipsychotic Agents - pharmacokinetics | Young Adult | Psychiatric Status Rating Scales | Analysis of Variance | Risperidone - therapeutic use | Time Factors | Antipsychotic Agents - therapeutic use | Adolescent | Least-Squares Analysis | Adult | Female | Palmitates - pharmacokinetics | Isoxazoles - therapeutic use | Schizophrenia - drug therapy | Drug Delivery Systems - methods | Index Medicus
Journal Article
Neuropsychopharmacology (New York, N.Y.), ISSN 0893-133X, 09/2010, Volume 35, Issue 10, pp. 2072 - 2082
injectable | antipsychotic | schizophrenia | paliperidone palmitate | efficacy | long acting | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Schizophrenia | Biological and medical sciences | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psycholeptics: tranquillizer, neuroleptic | Psychoses | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Body Mass Index | Palmitates - therapeutic use | Double-Blind Method | Humans | Middle Aged | Kaplan-Meier Estimate | Paliperidone Palmitate | Body Weight - drug effects | Male | Treatment Outcome | Evidence-Based Medicine | Case-Control Studies | Dose-Response Relationship, Drug | Injections | Psychiatric Status Rating Scales | Antipsychotic Agents - therapeutic use | Adult | Female | Isoxazoles - therapeutic use | Schizophrenia - drug therapy | Drug Delivery Systems - methods | Basal Ganglia Diseases - chemically induced | Index Medicus | development | psychiatry & behavioral sciences | trials | drug discovery | antipsychotics | clinical pharmacology | Original
Journal Article
BMC psychiatry, ISSN 1471-244X, 03/2012, Volume 12, Issue 1, pp. 26 - 26
Schizophrenia | Antipsychotics | Long-term therapy | Safety | Pharmacokinetics | Paliperidone palmitate | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psychiatric Status Rating Scales - statistics & numerical data | Prospective Studies | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Male | Schizophrenic Psychology | Dose-Response Relationship, Drug | Injections, Intramuscular - statistics & numerical data | Palmitates - administration & dosage | Antipsychotic Agents - therapeutic use | Treatment Failure | Adult | Female | Palmitates - adverse effects | Isoxazoles - pharmacokinetics | Palmitates - therapeutic use | Drug Administration Schedule | Schizophrenia - blood | Paliperidone Palmitate | Antipsychotic Agents - pharmacokinetics | Injections, Intramuscular - adverse effects | Isoxazoles - administration & dosage | Antipsychotic Agents - administration & dosage | Adolescent | Aged | Palmitates - pharmacokinetics | Isoxazoles - therapeutic use | Schizophrenia - drug therapy | Isoxazoles - adverse effects | Research | Drug therapy | Psychotropic drugs | Consent | Drug dosages | Manuscripts | Index Medicus
Journal Article